Pediatrix Medical Group Inc/ US58502B1061 /
2024-06-03 10:10:00 PM | Chg. +0.11 | Volume | Bid10:32:45 PM | Ask10:32:45 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
7.42USD | +1.50% | 1.93 mill. Turnover: 11.25 mill. |
7.11Bid Size: 100 | 8.80Ask Size: 200 | 624.37 mill.USD | - | 10.16 |
Assets
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 123.5360 | 133.0370 | 94.4920 | 76.1910 | 70.1540 | ||||||
Intangible Assets | 639.9280 | 588.3120 | 274.4070 | 26.6420 | 21.5650 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | 5,240.0430 | 5,277.5020 | 3,414.3940 | 1,798.6000 | 1,881.9820 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | 503.9990 | 542.2720 | 498.8690 | 241.9310 | 301.7750 | ||||||
Cash and Cash Equivalents | 60.2000 | 36.7450 | 112.7670 | 1,123.8430 | 387.3910 | ||||||
Current Assets | 627.2350 | 657.4090 | 731.5070 | 1,549.3480 | 840.5640 | ||||||
Total Assets | 5,867.2780 | 5,934.9110 | 4,145.9010 | 3,347.9480 | 2,722.5460 |
Liabilities
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | - | - | - | - | - | ||||||
Long-term debt | 1,851.4230 | 1,974.2800 | 1,730.2950 | 1,742.5860 | 1,002.2580 | ||||||
Liabilities to Banks | 1,110.5000 | 739.5000 | 0.0000 | - | - | ||||||
Provisions | 239.8000 | 161.8000 | 64.5000 | - | - | ||||||
Liabilities | 2,800.8240 | 2,847.0270 | 2,646.9050 | 2,600.2310 | 1,825.8540 | ||||||
Share Capital | .9370 | .8780 | .8420 | .8560 | .8640 | ||||||
Total Equity | 3,066.4540 | 3,087.8840 | 1,498.9960 | 747.7170 | 896.6920 | ||||||
Minority Interests | 0.0000 | - | - | .2320 | .2050 | ||||||
Total liabilities equity | 5,867.2780 | 5,934.9110 | 4,145.9010 | 3,347.9480 | 2,722.5460 |
Income Statement
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3,458.3120 | 3,647.1230 | 3,513.5420 | 1,733.9510 | 1,911.1910 | ||||||
Depreciation (total) | 102.8790 | 111.2810 | 78.8600 | 28.4410 | 32.1470 | ||||||
Operating Result | 480.0760 | 445.8480 | -1,136.0490 | 98.1320 | 202.9180 | ||||||
Interest Income | -74.5590 | -88.7690 | -119.3810 | -110.4820 | -68.7220 | ||||||
Income Before Taxes | 410.4220 | 368.8390 | -1,241.9800 | 7.1480 | 135.2280 | ||||||
Income Taxes | -90.0500 | -100.2100 | 91.8860 | -16.7280 | -27.2410 | ||||||
Minority Interests Profit | 0.0000 | - | - | - | .0270 | ||||||
Net Income | 320.3720 | 268.6290 | -1,497.7020 | -796.4880 | 130.9640 |
Per Share
Cash Flow
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 511.3780 | 289.9250 | 346.6370 | 204.6200 | 76.7370 | ||||||
Cash Flow from Investing Activities | -576.6130 | -142.7690 | 102.4550 | 815.5110 | -53.0730 | ||||||
Cash Flow from Financing | 89.7370 | -170.6110 | -393.0700 | -4.1580 | -760.1160 | ||||||
Decrease / Increase in Cash | 24.5020 | -23.4550 | 56.0220 | 1,015.9730 | -736.4520 | ||||||
Employees | 15,900 | 16,085 | 4,325 | - | - |